Get started
Author

DM Font

Observed names: D. Font, D.M. Font, Daniel Font
Observed institution: San Juan City Hospital
OpenAlex ID: A5085988223
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5
1067: From Anesthesia to Adversity: a Case Report on Lidocaine Anesthetic Systemic Toxicity (last)
2025 · Javier Torres, Sherley Rosa, et al. · Critical Care Medicine · 2
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases
PDF
1695: When Donor Cells Attack: Case Report on Passenger Lymphocyte Syndrome Posttransplant
2025 · Maria Perez-Mitchell, Javier Torres, et al. · Critical Care Medicine
Extrapulmonary Presentation of Asymptomatic Male in Lymphangioleiomyomatosis
2023 · C. Quiles-Cruz, J.J. Lopez-Fontanet, et al.
A Challenging Case of Refractory Pulmonary Alveolar Proteinosis
2023 · C. Quiles-Cruz, G.M. Gonzalez Santiago, et al.
Works count: 8
Citation count: 60
H-index: 3
I10-index: 2
Year
Topic
Type